Myung‐Ju Ahn

机构：Samsung Medical Center, Sungkyunkwan University · ORCID：0000-0002-5376-5109

发表论文 110 篇 · 总被引 2248 次 · h-index 25

代表论文

• Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02—A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC (2025 · Journal of Thoracic Oncology · 被引 22)
• Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report (2025 · Journal of Thoracic Oncology · 被引 12)
• Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer (2025 · European Journal of Cancer · 被引 7)
• Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial (2025 · Journal of Thoracic Oncology · 被引 5)
• A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America (2025 · Frontiers in Oncology · 被引 4)
• EGFR mutation testing across the osimertinib clinical program (2025 · Lung Cancer · 被引 4)